Osiris Legal Team Responds to False and Misleading Story by TheStreet.com

Earlier today, Osiris Therapeutics, Inc. , announced that it has reached agreement with the United States Food and Drug Administration regarding the regulatory pathway for its Biosurgery products, GrafixA and OvationA .

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131021006412&newsLang=en&ndmConfigId=1000639&vnsId=41